PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE TESTIS: IMPROVED OUTCOME WITH RITUXIMAB-CHOP WITH CNS AND CONTRALATERAL TESTIS PROPHYLAXIS. FINAL RESULTS OF IELSG 10 STUDY

被引：0
|
作者：
Vitolo, U. [1 ]
Zucca, E. [2 ]
Chiappella, A. [1 ]
Martelli, M. [1 ]
Balzarotti, M. [1 ]
Benevolo, G. [1 ]
De Masi, P. [1 ]
Filippi, A. [1 ]
Gospodarowicz, M. K. [2 ]
Lopez-Guillermo, A. [2 ]
Martinelli, G. [2 ]
Merli, F. [1 ]
Perrone, T. [1 ]
Pregno, P. [1 ]
Sarris, A. H. [2 ]
Storti, S. [1 ]
Cavalli, F. [2 ]
机构：
[1] San Giovanni Battista Hosp, IELSG & IIL, Turin, Italy
[2] IOSI, IELSG, Bellinzona, Switzerland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0401
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [21] Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study
    Hyun Ae Jung
    Silvia Park
    Jin Hyun Cho
    Seonwoo Kim
    Young Hyeh Ko
    Seok Jin Kim
    Won Seog Kim
    Annals of Hematology, 2012, 91 : 1747 - 1756
  • [22] Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study
    Jung, Hyun Ae
    Park, Silvia
    Cho, Jin Hyun
    Kim, Seonwoo
    Ko, Young Hyeh
    Kim, Seok Jin
    Kim, Won Seog
    ANNALS OF HEMATOLOGY, 2012, 91 (11) : 1747 - 1756
  • [23] Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
    Choi, Yong Won
    Jeong, Seong Hyun
    Ahn, Mi Sun
    Lee, Hyun Woo
    Kang, Seok Yun
    Choi, Jin-Hyuk
    Jin, U. Ram
    Park, Joon Seong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (11) : 1493 - 1500
  • [24] CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy
    Junshik Hong
    Sanghui Park
    Jinny Park
    Seung Jun Jang
    Hee Kyung Ahn
    Sun Jin Sym
    Eun Kyung Cho
    Dong Bok Shin
    Jae Hoon Lee
    Annals of Hematology, 2012, 91 : 1897 - 1906
  • [25] A miRNA Risk Score for the Prediction of Response to Rituximab-CHOP Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma
    Bahlis, Nizar J.
    Owen, Carolyn J.
    Neri, Paola
    Mansoor, Adnan
    Gratton, Kathy J.
    Duggan, Peter
    Ravani, Pietro
    Stewart, Douglas A.
    BLOOD, 2010, 116 (21) : 147 - 148
  • [26] CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy
    Hong, Junshik
    Park, Sanghui
    Park, Jinny
    Jang, Seung Jun
    Ahn, Hee Kyung
    Sym, Sun Jin
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    ANNALS OF HEMATOLOGY, 2012, 91 (12) : 1897 - 1906
  • [27] Neutropenic and Non-Neutropenic Fever In Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-CHOP Chemotherapy
    Park, Silvia
    Kim, Won Seog
    Kim, Seok Jin
    Hong, Jung Yong
    BLOOD, 2013, 122 (21)
  • [28] Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
    Tzankov, Alexandar
    Xu-Monette, Zijun Y.
    Gerhard, Marc
    Visco, Carlo
    Dirnhofer, Stephan
    Gisin, Nora
    Dybkaer, Karen
    Orazi, Attilio
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Ye, Qing
    Winter, Jane N.
    Farnen, John P.
    Piris, Miguel A.
    Moller, Michael B.
    You, M. James
    McDonnell, Timothy
    Medeiros, L. Jeffrey
    Young, Ken H.
    MODERN PATHOLOGY, 2014, 27 (07) : 958 - 971
  • [29] Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy
    Liu, Zhiyu
    Xu-Monette, Zijun Y.
    Cao, Xin
    Manyam, Ganiraju C.
    Wang, Xiaoxiao
    Tzankov, Alexandar
    Xia, Yi
    Li, Xin
    Visco, Carlo
    Sun, Ruifang
    Zhang, Li
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Parsons, Ben M.
    Moller, Michael B.
    Piris, Miguel A.
    Winter, Jane N.
    O'Malley, Dennis P.
    Medeiros, L. Jeffrey
    Young, Ken H.
    MODERN PATHOLOGY, 2015, 28 (10) : 1297 - 1314
  • [30] Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
    Delarue, Richard
    Tilly, Herve
    Mounier, Nicolas
    Petrella, Tony
    Salles, Gilles
    Thieblemont, Catherine
    Bologna, Serge
    Ghesquieres, Herve
    Hacini, Maya
    Fruchart, Christophe
    Ysebaert, Loic
    Ferme, Christophe
    Casasnovas, Olivier
    Van Hoof, Achiel
    Thyss, Antoine
    Delmer, Alain
    Fitoussi, Olivier
    Molina, Thierry Jo
    Haioun, Corinne
    Bosly, Andre
    LANCET ONCOLOGY, 2013, 14 (06): : 525 - 533
12345